Targeting Host Glycolysis as a Strategy for Antimalarial Development

Glycolysis controls cellular energy, redox balance, and biosynthesis. Antiglycolytic therapies are under investigation for treatment of obesity, cancer, aging, autoimmunity, and microbial diseases. Interrupting glycolysis is highly valued as a therapeutic strategy, because glycolytic disruption is g...

Descripción completa

Detalles Bibliográficos
Autores principales: Jezewski, Andrew J., Lin, Yu-Hsi, Reisz, Julie A., Culp-Hill, Rachel, Barekatain, Yasaman, Yan, Victoria C., D’Alessandro, Angelo, Muller, Florian L., Odom John, Audrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482815/
https://www.ncbi.nlm.nih.gov/pubmed/34604112
http://dx.doi.org/10.3389/fcimb.2021.730413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482815/
https://www.ncbi.nlm.nih.gov/pubmed/34604112
http://dx.doi.org/10.3389/fcimb.2021.730413

Ejemplares similares